An improved microtiter assay for evaluating anti-HIV-1 neutralizing antibodies from sera or plasma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
An improved microtiter assay for evaluating anti-HIV-1 neutralizing antibodies from sera or plasma ; volume:3 ; number:1 ; day:23 ; month:12 ; year:2003 ; pages:1-6 ; date:12.2003
BMC infectious diseases ; 3, Heft 1 (23.12.2003), 1-6, 12.2003
- Urheber
-
Zhang, Chiyu
- Beteiligte Personen und Organisationen
-
Chen, Yunyun
Ben, Kunlong
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-3-30
- URN
-
urn:nbn:de:1111-2016030245494
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhang, Chiyu
- Chen, Yunyun
- Ben, Kunlong
- SpringerLink (Online service)
Ähnliche Objekte (12)
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus
Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection
A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity
S021-05 OA. Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface
Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection
Evaluation of three alternative methods to the plaque reduction neutralizing assay for measuring neutralizing antibodies to dengue virus serotype 2
Broadly Neutralizing Antibodies for HIV Eradication
Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus
Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection
A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity
S021-05 OA. Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface
Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection
Evaluation of three alternative methods to the plaque reduction neutralizing assay for measuring neutralizing antibodies to dengue virus serotype 2
Broadly Neutralizing Antibodies for HIV Eradication
Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus
Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection
A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity
S021-05 OA. Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface
Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection
Evaluation of three alternative methods to the plaque reduction neutralizing assay for measuring neutralizing antibodies to dengue virus serotype 2
Broadly Neutralizing Antibodies for HIV Eradication